Corcept Shareholders: Contact Kaplan Fox before Lead Plaintiff Deadline Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT)…. Read MoreJoin Investigation
Stride, Inc. Kaplan Fox & Kilsheimer LLP is Investigating Stride, Inc. (LRN) for Potential Securities Law Violations… Read MoreJoin Investigation
CarMax, Inc. Kaplan Fox & Kilsheimer LLP is Investigating CarMax, Inc. (KMX) for Potential Securities Law Violations… Read MoreJoin Investigation
Barnes & Noble Education, Inc. Kaplan Fox is Investigating Barnes & Noble Education, Inc. (BNED) for Potential Securities Law Violations… Read MoreJoin Investigation
SelectQuote, Inc. Kaplan Fox & Kilsheimer LLP is Investigating SelectQuote and GoHealth following the DOJ’s Allegation of a Kickback Scheme involving SLQT and GOCO… Read MoreJoin Investigation
Unicycive Therapeutics, Inc. Kaplan Fox Announces an Investigation into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations… Read MoreJoin Investigation
Easterly ROCMuni High Income Municipal Bond Fund (formerly the Principal Street High Income Municipal Fund) — RMJAX; RMHVX; RMHIX; GSTFX; GSTEX; GSTAX Kaplan Fox Files Class Action to Recover Losses for Investors in the Easterly ROCMuni High Income Municipal Bond Fund (formerly the Principal Street High Income Municipal Fund) with Expanded Class Period of July 29, 2022 through June 12, 2025 — RMJAX; RMHVX; RMHIX; GSTFX; GSTEX; GSTAX… Read More
UroGen Pharma Ltd. Kaplan Fox Announces an Investigation into UroGen Pharma Ltd. (URGN) for Potential Securities Law Violations… Read MoreJoin Investigation
